Our whooping cough story, and why medical reporting is so interesting
One especially fascinating aspect of my job is sifting through medical history, something I was more than happy to do for my story on the resurgence of reported cases of...
Home > Reviews
All Stories
Long on decline, whooping cough makes a comeback
Hundreds of thousands of people in the U.S. -- many of them children -- were coming down with whooping cough each year when vaccines against "this menace," as one newspaper...
Our whooping cough story, and why medical reporting is so interesting
One especially fascinating aspect of my job is sifting through medical history, something I was more than happy to do for my story on the resurgence of reported cases of...
Long on decline, whooping cough makes a comeback
Hundreds of thousands of people in the U.S. -- many of them children -- were coming down with whooping cough each year when vaccines against "this menace," as one newspaper...
Science journal retracts controversial research paper
A scientific paper embraced by many chronic fatigue syndrome patients as a ray of hope has been retracted after a tumultuous year that included allegations of data manipulation and felony...
How we got details on questionable federal health research funding (You can look, too)
On Sunday and Monday of this week, we published a series examining 12 years of spending at one of the centers at the National Institutes of Health -- the National...
Troubled study at heart of therapy debate
With $30 million of taxpayer money, researchers set out to conduct one of the largest studies ever of an alternative medical treatment, a controversial therapy for coronary artery disease. The...
Study’s doctors have had their share of troubles
More than a dozen physicians involved with the Trial to Assess Chelation Therapy have run into trouble with federal regulators, state medical boards and even, in some cases, the law:...
Troubled study at heart of therapy debate
With $30 million of taxpayer money, researchers set out to conduct one of the largest studies ever of an alternative medical treatment, a controversial therapy for coronary artery disease. The...
Study’s doctors have had their share of troubles
More than a dozen physicians involved with the Trial to Assess Chelation Therapy have run into trouble with federal regulators, state medical boards and even, in some cases, the law:...